Reporting of noninferiority and equivalence randomized trials - An extension of the CONSORT Statement

被引:997
作者
Piaggio, G [1 ]
Elbourne, DR
Altman, DG
Pocock, SJ
Evans, SJW
机构
[1] WHO, Dept Reprod Hlth & Res, Stat & Informat Serv Grp, CH-1211 Geneva 27, Switzerland
[2] London Sch Hyg & Trop Med, Med Stat Unit, London WC1, England
[3] Ctr Stat Med, Oxford, England
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2006年 / 295卷 / 10期
关键词
D O I
10.1001/jama.295.10.1152
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The CONSORT (Consolidated Standards of Reporting Trials) Statement, including a checklist and a flow diagram, was developed to help authors improve their reporting of randomized controlled trials. Its primary focus was on individually randomized trials with 2 parallel groups that assess the possible superiority of one treatment compared with another but is now being extended to other trial designs. Noninferiority and equivalence trials have methodological features that differ from superiority trials and present particular difficulties in design, conduct, analysis, and interpretation. Although the rationale for such trials occurs frequently, those designed and described specifically as noninferiority or equivalence trials appear less commonly in the medical literature. The quality of reporting of those that are published is often inadequate. In this article, we present an adapted CONSORT checklist for reporting noninferiority and equivalence trials and provide illustrative examples and explanations for those items amended from the original CONSORT checklist. The intent is to improve reporting of noninferiority and equivalence trials, enabling readers to assess the validity of their results and conclusions.
引用
收藏
页码:1152 / 1160
页数:9
相关论文
共 66 条
[1]   The revised CONSORT statement for reporting randomized trials: Explanation and elaboration [J].
Altman, DG ;
Schulz, KF ;
Moher, D ;
Egger, M ;
Davidoff, F ;
Elbourne, D ;
Gotzsche, PC ;
Lang, T .
ANNALS OF INTERNAL MEDICINE, 2001, 134 (08) :663-694
[2]  
[Anonymous], 2000, POINTS CONS SWITCH S
[3]  
[Anonymous], STAT PRINC CLIN TRIA
[4]   Improving the quality of reporting of randomized controlled trials - The CONSORT statement [J].
Begg, C ;
Cho, M ;
Eastwood, S ;
Horton, R ;
Moher, D ;
Olkin, I ;
Pitkin, R ;
Rennie, D ;
Schulz, KF ;
Simel, D ;
Stroup, DF .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (08) :637-639
[5]   Oral pristinamycin versus standard penicillin regimen to treat erysipelas in adults: randomised, non-inferiority, open trial [J].
Bernard, P ;
Chosidow, O ;
Vaillant, L .
BMJ-BRITISH MEDICAL JOURNAL, 2002, 325 (7369) :864-866
[6]   A comparison of intent-to-treat and per-protocol results in antibiotic non-inferiority trials [J].
Brittain, E ;
Lin, D .
STATISTICS IN MEDICINE, 2005, 24 (01) :1-10
[7]   CONSORT statement: extension to cluster randomised trials [J].
Campbell, MK ;
Elbourne, DR ;
Altman, DG .
BMJ-BRITISH MEDICAL JOURNAL, 2004, 328 (7441) :702-708
[8]   A RANDOMIZED CONTROLLED TRIAL TO TEST EQUIVALENCE BETWEEN RETINYL PALMITATE AND BETA-CAROTENE FOR VITAMIN-A-DEFICIENCY [J].
CARLIER, C ;
COSTE, J ;
ETCHEPARE, M ;
PERIQUET, B ;
AMEDEEMANESME, O .
BRITISH MEDICAL JOURNAL, 1993, 307 (6912) :1106-1110
[9]   Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicentre randomised double-blind study [J].
Chadwick, D .
LANCET, 1999, 354 (9172) :13-19
[10]   Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen [J].
Chan, FKL ;
Chung, SCS ;
Suen, BY ;
Lee, YT ;
Leung, WK ;
Leung, VKS ;
Wu, JCY ;
Lau, JYW ;
Hui, Y ;
Lai, MS ;
Chan, HLY ;
Sung, JJY .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (13) :967-973